Log In
Print
BCIQ
Print
Print this Print this
 

Neo-Urinary Conduit

  Manage Alerts
Collapse Summary General Information
Company Tengion Inc.
DescriptionAutologous implant that catalyzes regeneration of bladder tissue
Molecular Target
Mechanism of Action 
Therapeutic ModalityCell therapy: Organ/tissue engineering
Latest Stage of DevelopmentPhase I
Standard IndicationBladder cancer
Indication DetailsRegenerate bladder tissue for bladder cancer patients requiring a urinary diversion following bladder removal; Treat bladder dysfunction requiring incontinent urinary diversion
Regulatory Designation

U.S. - Orphan Drug (Treat bladder dysfunction requiring incontinent urinary diversion)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today